Search results for "Contraindication"

showing 10 items of 67 documents

Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies

2020

ObjectivesPelvic side wall infiltration by gynecological malignancies has been considered for a long time an absolute contraindication to curative resection. The development of the laterally extended endopelvic resection (LEER) has challenged this surgical paradigm. Although the LEER has been standardized in open surgery, only small studies have been published about its endoscopic feasibility. The objective of this study is to analyze the safety of LEER in patients with gynecological malignancies involving the pelvic side wall.MethodsWe retrospectively evaluated a consecutive series of patients who underwent a laparoscopically modified LEER between July 2014 and November 2018. This indicate…

Adultmedicine.medical_specialtyGenital Neoplasms Femalemedicine.medical_treatmentgenital neoplasmRectumPelvissurgical oncologyGynecologic Surgical ProcedureslaparoscopeMedicineHumansHemoperitoneumHydronephrosisContraindicationPelvisAgedRetrospective Studiesbusiness.industryUrinary retentiongynecologyObstetrics and GynecologypelviMiddle Agedmedicine.diseaseSurgerylaparoscopesSettore MED/40 - GINECOLOGIA E OSTETRICIAmedicine.anatomical_structurefemaleOncologygenital neoplasmsConcomitantNephrostomysurgical oncology.Laparoscopymedicine.symptombusiness
researchProduct

Manejo de la hiperglucemia con fármacos no insulínicos en pacientes adultos con diabetes tipo 2

2019

Resumen: El adecuado tratamiento de la diabetes mellitus tipo 2 (DM2) incluye la alimentación saludable y el ejercicio (150 min/semana) como pilares básicos. Para el tratamiento farmacológico, la metformina es el fármaco de elección inicial, salvo contraindicación o intolerancia; en caso de mal control, se dispone de 8 familias terapéuticas (6 orales y 2 inyectables) como posibles combinaciones. Se presenta un algoritmo y unas recomendaciones para el tratamiento de la DM2. En prevención secundaria cardiovascular se recomienda asociar un inhibidor del cotransportador sodio-glucosa tipo 2 (iSGLT2) o un agonista del receptor de glucagon-like peptide-1 (arGLP1) en pacientes con obesidad. En pre…

Agonistmedicine.medical_specialtymedicine.drug_class030204 cardiovascular system & hematologyOverweight:Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet::Diabetic Diet [Medical Subject Headings]GastroenterologyDiabetes tipo 2:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]03 medical and health sciences0302 clinical medicineFármacos antidiabéticos:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Hyperglycemia [Medical Subject Headings]Internal medicineDiabetes mellitusmedicineGliclazide030212 general & internal medicineHiperglucemiaContraindicationlcsh:R5-920business.industryAntidiabetic drugs:Diseases::Endocrine System Diseases::Diabetes Mellitus::Diabetes Mellitus Type 2 [Medical Subject Headings]nutritional and metabolic diseases:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology Social::Life Style [Medical Subject Headings]Type 2 diabetesGeneral Medicinemedicine.diseaseSulfonylureaObesityHumanos:Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesity [Medical Subject Headings]MetforminHyperglycemia:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hypoglycemic Agents [Medical Subject Headings]medicine.symptomlcsh:Medicine (General)Family Practicebusinessmedicine.drug
researchProduct

Rational Management of Macroglossia Due to Acquired Systemic Amyloidosis: Does Surgery Play a Role?

2008

Amyloidmedicine.medical_specialtyFatal outcomemedicine.medical_treatmentMEDLINEFatal OutcomeTracheostomyMacroglossiaTonguemedicineMacroglossiaHumansGastrostomyGlossectomybusiness.industryContraindicationsAmyloidosisAmyloidosisMiddle Agedmedicine.diseaseSystemic amyloidosisGastrostomySurgerymedicine.anatomical_structureOtorhinolaryngologyGlossectomyFemaleImmunoglobulin Light ChainsSurgeryOral Surgerymedicine.symptomMultiple MyelomabusinessJournal of Oral and Maxillofacial Surgery
researchProduct

Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thora…

2012

Thoracic endovascular aortic repair (TEVAR) is an emerging treatment modality, which has been rapidly embraced by clinicians treating thoracic aortic disease.1–4 Fundamentally, it is a far less invasive approach than open surgery and its availability and relative ease of application has changed and extended management options in thoracic aortic disease, including in those patients deemed unfit or unsuitable for open surgery. In the operating room, this requires considerable perceptual, cognitive and psychomotor demands on the operators. The dramatic expansion of TEVAR activity has necessarily prompted a requirement to systematically consider the indications, appropriateness, limitations and…

Aortic archEndoleakMedizinAnastomotic LeakAorta ThoracicChest painPatient Care PlanningAortic aneurysmPostoperative ComplicationsIntraoperative ComplicationsBrain DiseasesEndovascular ProceduresAngiographyEquipment DesignGeneral MedicineTreatment OutcomeCardiothoracic surgeryDescending aortacardiovascular systemCardiologyStentsmedicine.symptomCardiology and Cardiovascular MedicinePulmonary and Respiratory Medicinemedicine.medical_specialtyConsensusAortic DiseasesPerioperative CareSpinal Cord DiseasesBlood Vessel Prosthesis ImplantationAneurysmBlood vessel prosthesismedicine.arteryInternal medicineMonitoring IntraoperativemedicineHumansAortaAortic Aneurysm Thoracicbusiness.industryContraindicationsPatient SelectionVascular System Injuriesmedicine.diseaseSurgeryBlood Vessel ProsthesisAortic DissectionSurgerybusinessTomography X-Ray ComputedEchocardiography TransesophagealEuropean Journal of Cardio-Thoracic Surgery
researchProduct

Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic thera…

1999

The benefit of primary angioplasty in patients with acute myocardial infarction (AMI) and contraindications for thrombolysis compared to a conservative regimen is still unclear. Out of 5,869 patients with AMI registered by the MITRA trial, 337 (5.7%) patients had at least one strong contraindication for thrombolytic therapy. Out of these 337 patients 46 (13.6%) were treated with primary angioplasty and 276 (86.4%) were treated conservatively. Patients treated conservatively were older (70 years vs. 60 years; P = 0.001), had a higher rate of a history with chronic heart failure (14.8% vs. 4.4%; P = 0.053), a higher heart rate at admission (86 beats/min vs. 74 beats/min; P = 0.001), and a hig…

Aspirinmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentGeneral MedicineThrombolysismedicine.diseaseRegimenInternal medicineDiabetes mellitusHeart failureHeart ratemedicineCardiologyRadiology Nuclear Medicine and imagingMyocardial infarctionCardiology and Cardiovascular MedicinebusinessContraindicationmedicine.drugCatheterization and Cardiovascular Interventions
researchProduct

Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal re…

2014

Background The incidence of acute kidney injury (AKI) is estimated at 10 to 20% in patients admitted to intensive care units (ICU) and often requires renal replacement therapy (RRT). ICU mortality in AKI patients can exceed 50%. Venous catheters are the preferred vascular access method for AKI patients requiring RRT, but carry a risk of catheter thrombosis or infection. Catheter lock solutions are commonly used to prevent such complications. Heparin and citrate locks are both widely used for tunneled, long-term catheters, but few studies have compared citrate versus heparin for patients with short-term, non-tunneled catheters. We aim to compare citrate 4% catheter lock solution versus hepar…

Catheter Obstructionmedicine.medical_specialtyCatheterization Central VenousTime Factorsmedicine.medical_treatmentHemodialysis CatheterCatheter ObstructionMedicine (miscellaneous)urologic and male genital diseasesHospitals UniversityStudy ProtocolAcute renal failureClinical ProtocolsDouble-Blind MethodRenal DialysisCitrate lockIntensive careUpper Extremity Deep Vein ThrombosisProhibitinsmedicineCentral Venous CathetersHumansPharmacology (medical)Heparin lockRenal replacement therapyCitratesProspective StudiesContraindicationbusiness.industryHeparinAcute kidney injuryAnticoagulantsEquipment DesignAcute Kidney Injurymedicine.diseasefemale genital diseases and pregnancy complicationsSurgeryCatheterIntensive Care UnitsTreatment OutcomeResearch DesignHemodialysisHemodialysisFranceCritically ill patientbusinessCatheter lockTrials
researchProduct

Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of …

2022

Corticosteroids (CSs) are widely used in oncology, presenting several different indications. They are useful for induction of apoptosis in hematological neoplasms, for management of anaphylaxis and cytokine release/hypersensitivity reaction and for the symptomatic treatment of many tumour- and treatment-related complications. If the employment of CSs in the oncological setting results in several benefits for patients and satisfaction for clinicians, on the other hand, many potential adverse events (AEs), both during treatment and after withdrawal of CSs, as well as the duality of the effects of these compounds in oncology, recommend being cautious in clinical practice. To date, several gray…

ConsensusSurvivalTumour responseSettore MED/06 - Oncologia MedicaContraindicationsHematologyMedical OncologyItalyOncologyAdrenal Cortex HormonesDoseAdverse eventsHumansCorticosteroidsIndicationsGlucocorticoidsSocieties MedicalCancer
researchProduct

Treatment of Gingival Recession: When and How?

2021

Gingival recession is a common finding in daily clinical practice. Several issues may be associated with the apical shift of the gingival margin such as dentine hypersensitivity, root caries, non-carious cervical lesions (NCCLs), and compromised aesthetics. The first step in an effective management and prevention program is to identify susceptibility factors and modifiable conditions associated with gingival recession. Non-surgical treatment options for gingival recession defects include establishment of optimal plaque control, removal of overhanging subgingival restorations, behaviour change interventions, and use of desensitising agents. In cases where a surgical approach is indicated, co…

Dentine hypersensitivityGingivaConnective tissueDentistryGingival recessionSurgical Flaps03 medical and health sciences0302 clinical medicineMucogingival surgerymedicineHumansBehaviour change interventionsAcellular Dermis030212 general & internal medicine610 Medicine & healthGeneral DentistryGingival recessionContraindicationRoot cariesSoft tissue managementbusiness.industryRK1-715Effective management030206 dentistryTreatment Outcomemedicine.anatomical_structureConnective TissueDentistrymedicine.symptombusinessGingival marginInternational Dental Journal
researchProduct

General Diagnosis and Medical Evaluation

2019

Current literature does not contribute to a high level of evidence regarding possible indications for immediate loading. A great variety of exclusion criteria for immediate loading of dental implants are used in different studies. However, the reported criteria are similar to those chosen for conventional loading of dental implants. Despite its several clinical advantages, the immediate loading protocol should be performed respecting a rigorous preliminary diagnostic algorithm. Primary indication for immediate implant loading is certainly patients’ desire to reduce the overall treatment time. Additionally, several psychological factors, related to the preservation of functional and esthetic…

EdentulismReconstructive surgerymedicine.medical_specialtybusiness.industryDentistryMedical evaluationEvidence-based medicinemedicine.diseaseOral hygieneImmediate loadingMedicineImplantbusinessContraindication
researchProduct

Early cardiac unloading with ImpellaCP™ in acute myocardial infarction with ventricular septal defect

2020

Abstract Despite a relative contraindication, mechanical support with Impella™ left ventricular assist device has already been described for ischaemic ventricular septal defect treatment, either as a bridge to surgery, as intraoperative mechanical haemodynamic support, or to ensure intraprocedural haemodynamic stability during device closure. We describe two cases of ventricular septal defect complicating acute myocardial infarction, where the percutaneous ImpellaCP was implanted early (differently than previously described) with the aim of preventing haemodynamic instability, while deferring surgical repair. We present a report of haemodynamic, echocardiographic, biochemical, and clinical …

Heart Septal Defects Ventricularmedicine.medical_specialtyPercutaneousAcute myocardial infarction mechanical complicationmedicine.medical_treatmentMyocardial InfarctionCase ReportLeft ventricular assist device610 Medicine & health030204 cardiovascular system & hematologyVentricular septal defectImpella11171 Cardiocentro Ticino2705 Cardiology and Cardiovascular Medicine03 medical and health sciences0302 clinical medicineInternal medicineDiseases of the circulatory (Cardiovascular) systemMedicineHumans030212 general & internal medicineMyocardial infarctioncardiovascular diseasesContraindicationImpellaSurgical repairbusiness.industryHemodynamicsAcute heart failureHeartPerioperativemedicine.diseaseRC666-701Heart failureVentricular assist deviceCardiologyHeart-Assist DevicesCardiology and Cardiovascular Medicinebusiness
researchProduct